95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.80%
Negative revenue growth while FSM stands at 0.44%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-3.19%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-3.19%
Negative EBIT growth while FSM is at 27.73%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-3.19%
Negative operating income growth while FSM is at 27.73%. Joel Greenblatt would press for urgent turnaround measures.
-278.54%
Negative net income growth while FSM stands at 998.31%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-284.62%
Negative EPS growth while FSM is at 1011.11%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-284.62%
Negative diluted EPS growth while FSM is at 1011.11%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.06%
Share count expansion well above FSM's 0.08%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.06%
Slight or no buyback while FSM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-51.94%
Dividend reduction while FSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-8.92%
Negative OCF growth while FSM is at 250.84%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-8.51%
Negative FCF growth while FSM is at 156.46%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
250.27%
10Y CAGR of 250.27% while FSM is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
40.54%
5Y revenue/share CAGR under 50% of FSM's 85.24%. Michael Burry would suspect a significant competitive gap or product weakness.
-16.83%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
417.66%
10Y OCF/share CAGR above 1.5x FSM's 119.29%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
20.23%
Below 50% of FSM's 162.71%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-32.27%
Negative 3Y OCF/share CAGR while FSM stands at 23.95%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-721.54%
Negative 10Y net income/share CAGR while FSM is at 167.21%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-217.95%
Negative 5Y net income/share CAGR while FSM is 187.28%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-170.14%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
934.73%
10Y equity/share CAGR above 1.5x FSM's 6.55%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
86.95%
5Y equity/share CAGR above 1.5x FSM's 55.39%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
27.75%
3Y equity/share CAGR above 1.5x FSM's 6.17%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-59.03%
Negative near-term dividend growth while FSM invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-16.89%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-3.73%
Negative asset growth while FSM invests at 1.57%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.85%
We have a declining book value while FSM shows 0.82%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-9.51%
We’re deleveraging while FSM stands at 0.64%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-14.70%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.